<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>B. Zhang | SONG LAB</title><link>https://playful-bavarois-78840e.netlify.app/author/b.-zhang/</link><atom:link href="https://playful-bavarois-78840e.netlify.app/author/b.-zhang/index.xml" rel="self" type="application/rss+xml"/><description>B. Zhang</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Sat, 01 Aug 2026 00:00:00 +0000</lastBuildDate><image><url>https://playful-bavarois-78840e.netlify.app/media/logo_hu11652092127514912302.png</url><title>B. Zhang</title><link>https://playful-bavarois-78840e.netlify.app/author/b.-zhang/</link></image><item><title>Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistance</title><link>https://playful-bavarois-78840e.netlify.app/publication/cysltr1-tumor-promoting-myelopoiesis/</link><pubDate>Sat, 01 Aug 2026 00:00:00 +0000</pubDate><guid>https://playful-bavarois-78840e.netlify.app/publication/cysltr1-tumor-promoting-myelopoiesis/</guid><description/></item><item><title>4-1BB stimulation with concomitant inactivation of adenosine A2B receptors enhances CD8+ T cell antitumor response</title><link>https://playful-bavarois-78840e.netlify.app/publication/4-1bb-a2b-cd8-tumor-response/</link><pubDate>Mon, 02 Jun 2025 00:00:00 +0000</pubDate><guid>https://playful-bavarois-78840e.netlify.app/publication/4-1bb-a2b-cd8-tumor-response/</guid><description/></item><item><title>Toroidal-spiral particles as a CAR-T cell delivery device for solid tumor immunotherapy</title><link>https://playful-bavarois-78840e.netlify.app/publication/toroidal-spiral-particles-car-t/</link><pubDate>Sun, 01 Oct 2023 00:00:00 +0000</pubDate><guid>https://playful-bavarois-78840e.netlify.app/publication/toroidal-spiral-particles-car-t/</guid><description/></item></channel></rss>